Maria Miranda

Dr. Maria Miranda

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MMMaría Muriach
María Muriach
FBFrancisco Bosch-Morell
Francisco Bosch-Morell
GAGeorge Alexander
George Alexander
RBRune Blomhoff
Rune Blomhoff
JBJorge M. Barcia
Jorge M. Barcia
MMMaria Miranda
Maria Miranda

8 July 2008 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
DSDolores Silvestre
Dolores Silvestre
MMMaria Miranda
Maria Miranda
MMMaría Muriach
María Muriach
IAInmaculada Almansa
Inmaculada Almansa
EJEnrique Jareño
Enrique Jareño
FRFrancisco J. Romero
Francisco J. Romero

1 November 2009 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
EAEmma Arnal
Emma Arnal
MMMaria Miranda
Maria Miranda
SJSiv Johnsen-Soriano
Siv Johnsen-Soriano
RARaquel Alvarez-Nölting
Raquel Alvarez-Nölting
MDManuel Díaz-Llopis
Manuel Díaz-Llopis
FRFrancisco J. Romero
Francisco J. Romero
Purpose: To assess the effect of docosahexanoic acid (DHA) and lutein (both compounds with anti-inflammatory and antioxidant properties) on experimental diabetic retinopathy. Methods: Male Wistar rats were studied: non-diabetic controls, untreated diabetic controls, and diabetic rats were treated with DHA and lutein or the combination of DHA + insulin and lutein + insulin for 12 weeks. Oxidative stress and inflammatory markers, apoptosis, and functional tests were studied to confirm biochemical and functional changes in the retina of diabetic rats. Malondialdehyde (MDA), glutathione concentrations (GSH), and glutathione peroxidase activity (GPx) were measured as oxidative stress markers. TUNEL assay and caspase-3 immunohistochemistry and electroretinogram were performed. Results: Diabetes increases oxidative stress, nitrotyrosine concentrations, and apoptosis in the retina. At 12 weeks after onset of diabetes, total thickness of retinas of diabetic rats was significantly less than that in control rats. Specifically, the thickness of the outer and inner nuclear layers was reduced significantly in diabetic rats and demonstrated a loss of cells in the GCL. These retinal changes were avoided by the administration of insulin and DHA and lutein alone or in combination with insulin. Impairment of the electroretinogram (b-wave amplitude and latency time) was observed in diabetic rats. DHA and lutein prevented all these changes even under hyperglycemic conditions. Conclusions: Lutein and DHA are capable of normalizing all the diabetes-induced biochemical, histological, and functional modifications. Specifically, the cell death mechanisms involved deserve further studies to allow the proposal as potential adjuvant therapies to help prevent vision loss in diabetic patients.

3 September 2008 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
EAEmma Arnal
Emma Arnal
MMMaria Miranda
Maria Miranda
IAInmaculada Almansa
Inmaculada Almansa
MMMaría Muriach
María Muriach
JBJorge M. Barcia
Jorge M. Barcia
FBFrancisco Bosch-Morell
Francisco Bosch-Morell

24 July 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LTLaura Trachsel-Moncho
Laura Trachsel-Moncho
SBSoledad Benlloch-Navarro
Soledad Benlloch-Navarro
ÁFÁngel Fernández-Carbonell
Ángel Fernández-Carbonell
DRDolores Tania Ramírez-Lamelas
Dolores Tania Ramírez-Lamelas
TOTeresa Olivar
Teresa Olivar
MMMaria Miranda
Maria Miranda
Retinitis pigmentosa (RP) is an inherited retinopathy that leads to photoreceptor loss. RP has been related to oxidative stress, autophagy, and inflammation. This study aimed to identify changes in the levels of oxidative stress and autophagy markers in the retina of control and rd10 mice during different phases of retinal development. Changes in the retinal oxidation system were investigated by measuring the levels of oxidized and reduced glutathione (GSH/GSSG), retinal avidin-positive cells, and 4-hydroxynonenal (4-HNE) staining intensity. Autophagy characterization was explored by measuring the levels of microtubule-associated protein 1 light chain 3 (LC3), beclin, autophagy-related proteins 5 and 7 (Atg5 and Atg7), and lysosomal associated membrane protein-2A (LAMP-2A). At P28 retinal GSH concentrations decreased in rd10 mice compared to the controls. No differences were found in retinal GSSG concentrations between the control and rd10 mice. There was an increase in retinal GSSG concentrations and a decrease in the GSH/GSSG ratio in the control and rd10 mice at P21 and P28 compared to P13. We observed an increase in avidin-positive cells in rd10 retinas. 4-HNE was increased in rd10 retinas at P13, and it also increased in control mice with age. We did not observe any differences in the retinal levels of LC3II/I ratio, Beclin, Atg5, or Atg7 in the rd10 mice compared to the controls. There was an increase in the LAMP-2A concentrations in the control and rd10 mice with development age (P28 concentrations vs. P13). Although only slight differences were found in the oxidative stress and autophagy markers between the control and rd10 mice, there were increases in the GSSG, 4-HNE, and LAMP-2A with age. This increase in the oxidative stress and chaperone-mediated autophagy has not been described before and occurred just after the mice opened their eyes, potentially indicating a retinal response to light exposure.

11 November 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
ACAntolin Canto Catala
Antolin Canto Catala
TOTeresa Olivar
Teresa Olivar
FRFrancisco J. Romero
Francisco J. Romero
MMMaria Miranda
Maria Miranda
Nitric oxide (NO) is a gas molecule with diverse physiological and cellular functions. In the eye, NO is used to maintain normal visual function as it is involved in photoreceptor light transduction. In addition, NO acts as a rapid vascular endothelial relaxant, is involved in the control of retinal blood flow under basal conditions and mediates the vasodilator responses of different substances such as acetylcholine, bradykinin, histamine, substance P or insulin. However, the retina is rich in polyunsaturated lipid membranes and is sensitive to the action of reactive oxygen and nitrogen species. Products generated from NO (i.e., dinitrogen trioxide (N2O3) and peroxynitrite) have great oxidative damaging effects. Oxygen and nitrogen species can react with biomolecules (lipids, proteins and DNA), potentially leading to cell death, and this is particularly important in the retina. This review focuses on the role of NO in several ocular diseases, including diabetic retinopathy, retinitis pigmentosa, glaucoma or age-related macular degeneration (AMD).